A Comparison of CD4 T Cell Induction and Antibody Responses Between a Pure Hemagglutinin Influenza Vaccine (rHA, Protein Sciences Corp) and Licensed Subvirion Influenza Vaccine Made in Eggs (Sanofi) or Cell Culture (Novartis) in Healthy Adults.
Phase of Trial: Phase IV
Latest Information Update: 09 May 2018
At a glance
- Drugs Influenza vaccine (Optaflu) (Primary) ; Influenza virus RIV3 vaccine-(FluBlok) (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 30 Apr 2018 Planned End Date changed from 30 Jun 2018 to 30 Jun 2020.
- 30 Apr 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Jun 2019.
- 08 Mar 2017 New trial record